Latest Breaking News On - Supplementary protection certificate - Page 2 : comparemela.com

STADA and Alvotech's win first EU-approval for Stelara biosimilar - Pharmaceutical Technology

STADA and Alvotech’s Uzpruvo gained an EU marketing authorisation, allowing it to be sold in the European Economic Area in 2024.

Mithra Completes Pediatric Study of ESTELLE in Adolescent Patients

20.12.2023 - Mithra Completes Pediatric Study of ESTELLE in Adolescent Patients Important milestone for Mithra’s commitment to bring benefits of ESTELLE to more womenPotential EMA approval in pediatric population could lead to six-month extension of the . Seite 1

Mithra Pharmaceuticals: Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

JPM2024: transactional considerations in view of a (proposed) broader Bolar exemption in EU | Hogan Lovells

Recent European Commission (Commission) proposals, including a broadening of the so-called ‘Bolar exemption’, would substantially change various incentive schemes related to medicinal.